French sustainable chemistry firm Afyren reported encouraging results for the 2025 fiscal year. Driven by its Afyren NEOXY plant in the Grand Est region, the company produced 400 tonnes of bio-based acids over the year. Production pace accelerated significantly in the fourth quarter, which alone accounted for half of the total volumes. Current output is fully committed to nine customers, including a strategic contract secured in the flavors and fragrances sector.

Afyren has reached a key milestone by taking 100% control of Afyren NEOXY. The group acquired the 49% stake held by Bpifrance for 11.3 million euros in cash. This integration simplifies governance and bolsters management's confidence: according to Afyren, this single plant is now sufficient to ensure the group's future profitability.

On the financial front, the balance sheet remains solid with a cash position of 35.2 million euros. While the fiscal year ended with a net loss of 14.4 million euros, this is primarily attributed to massive investments and operational expenses related to the industrial scale-up of the plant.

For the 2026-2027 period, the group plans to invest 20 million euros to debottleneck the production site and optimize capacity. The objective is clear: boost sales to reach EBITDA breakeven by 2028.

International ambitions remain intact. Afyren is maintaining its expansion projects, including a plant in Thailand (target capacity of 28 kt/year) and another planned unit in France (+24 kt/year).